C1q deficiency in an Inuit family: identification of a new class of C1q disease-causing mutations
Hanne Vibeke Marquart1, Lone Schejbel, Anders Sjoholm
1Dept. of Clinical Immunology sect. 7631, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Denmark. hanne.marquart@rh.hosp.dk <hanne.marquart@rh.hosp.dk>
Insights
C1q deficiency, linked to lupus and infections, was studied in Inuit sisters. A novel mutation in the C1q B chain was identified, causing undetectable C1q levels and defining a new deficiency mechanism.
Area of Science:
- Immunology
- Genetics
- Rare Diseases
Background:
- C1q deficiency is a rare genetic disorder.
- It is associated with systemic lupus erythematosus (SLE)-like symptoms and recurrent infections.
- The classical complement pathway is impaired in C1q deficiency.
Purpose of the Study:
- To investigate the molecular basis of C1q deficiency in three Inuit sisters.
- To identify the genetic cause of impaired classical complement pathway function.
Main Methods:
- Patients' sera were analyzed for complement pathway function and C1q levels.
- Genetic sequencing of C1q genes was performed.
- Family members and healthy controls were genotyped.
Main Results:
- The patients exhibited no function in the classical complement pathway, while lectin and alternative pathways were intact.
- No C1q or low molecular weight C1q was detected in patient sera.
- A novel missense mutation (Gly-Arg) in codon 217 of the C1q B chain was identified.
- All affected sisters were homozygous for the mutation, with heterozygous parents and no affected controls.
Conclusions:
- A novel missense mutation in the C1q B chain is the cause of C1q deficiency in this family.
- This finding represents a third class of molecular mechanisms for C1q deficiency.
- Missense mutations can lead to a complete lack of detectable C1q antigen in serum.
Abstract:
C1q deficiency is a rare condition associated with a systemic lupus erythematosus (SLE)-like syndrome and recurrent infections. Here we present the molecular basis behind C1q deficiency in three sisters of Inuit origin. Initial examination for complement deficiency showed no function of the classical complement activation pathway in the patients; the lectin and alternative pathways were intact. No C1q or low molecular weight C1q was detected in sera and no anti-C1q autoantibodies were found. Sequencing of the C1q genes revealed a novel missense mutation (Gly-Arg) in codon 217 of the B chain. All sisters were homozygous for the mutation: both parents were heterozygous. None of 100 healthy controls carried the mutation. Our findings define a third class of molecular mechanisms behind C1q deficiency, where missense mutations cause a lack of detectable C1q-antigen in serum.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pedigree Analysis
Incomplete Dominance
Inflammatory Bowel Disease III: Crohn's Disease

